Total Holdings
169
Portfolio diversification across 169 positions
LABU
(NYSEARCA)Direxion Daily S&P Biotech Bull 3X ETF
$279.02-- (--)
Loading... - Market loading
LABU ETF Holdings: Direxion Daily S&P Biotech Bull 3X ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$543.30M
Total fund assets
Expense Ratio
0.96%
Annual management fee
Fund Issuer
Direxion
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 47 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | TG Therapeutics, Inc | Stock | 1.26% |
| 2 |  | Travere Therapeutics Inc | Stock | 1.22% |
| 3 |  | Alkermes plc | Stock | 1.19% |
| 4 |  | Twist Bioscience Corporation | Stock | 1.16% |
| 5 |  | Revolution Medicines, Inc | Stock | 1.10% |
| 6 |  | Exelixis, Inc | Stock | 0.94% |
| 7 |  | Arrowhead Pharmaceuticals, Inc | Stock | 0.94% |
| 8 |  | Krystal Biotech, Inc | Stock | 0.93% |
| 9 |  | Neurocrine Biosciences, Inc | Stock | 0.93% |
| 10 |  | Apogee Therapeutics, Inc. | Stock | 0.92% |
| 11 |  | Nuvalent Inc | Stock | 0.91% |
| 12 |  | Incyte Corporation | Stock | 0.84% |
| 13 |  | Protagonist Therapeutics Inc | Stock | 0.84% |
| 14 |  | PTC Therapeutics, Inc | Stock | 0.84% |
| 15 |  | Beam Therapeutics Inc | Stock | 0.83% |
| 16 |  | Erasca, Inc. | Stock | 0.83% |
| 17 |  | Natera, Inc | Stock | 0.82% |
| 18 |  | Oruka Therapeutics, Inc. | Stock | 0.82% |
| 19 |  | Madrigal Pharmaceuticals, Inc | Stock | 0.81% |
| 20 |  | Veracyte, Inc | Stock | 0.81% |
| 21 |  | Cytokinetics, Incorporated | Stock | 0.80% |
| 22 |  | Kymera Therapeutics, Inc. | Stock | 0.80% |
| 23 |  | Mirum Pharmaceuticals Inc | Stock | 0.80% |
| 24 |  | Halozyme Therapeutics, Inc | Stock | 0.78% |
| 25 |  | Biogen Inc | Stock | 0.77% |
| 26 |  | Scholar Rock Holding Corp | Stock | 0.76% |
| 27 |  | Dianthus Therapeutics, Inc. | Stock | 0.76% |
| 28 |  | Viking Therapeutics, Inc. | Stock | 0.76% |
| 29 |  | Spyre Therapeutics Inc. | Stock | 0.75% |
| 30 |  | CRISPR Therapeutics AG | Stock | 0.74% |
| 31 |  | Roivant Sciences Ltd | Stock | 0.74% |
| 32 |  | Praxis Precision Medicines, Inc. | Stock | 0.74% |
| 33 |  | United Therapeutics Corporation | Stock | 0.74% |
| 34 |  | Arcutis Biotherapeutics, Inc | Stock | 0.73% |
| 35 |  | Immunovant Inc | Stock | 0.73% |
| 36 |  | AbbVie Inc | Stock | 0.73% |
| 37 |  | Ionis Pharmaceuticals, Inc | Stock | 0.73% |
| 38 |  | Cogent Biosciences, Inc. | Stock | 0.72% |
| 39 |  | Moderna, Inc. | Stock | 0.72% |
| 40 |  | CG Oncology, Inc. | Stock | 0.72% |
| 41 |  | Rhythm Pharmaceuticals, Inc | Stock | 0.72% |
| 42 |  | Vaxcyte, Inc. | Stock | 0.70% |
| 43 |  | BridgeBio Pharma, Inc | Stock | 0.70% |
| 44 |  | Amgen Inc | Stock | 0.69% |
| 45 |  | BioMarin Pharmaceutical Inc | Stock | 0.68% |
| 46 |  | Vertex Pharmaceuticals Incorporated | Stock | 0.67% |
| 47 |  | Alnylam Pharmaceuticals, Inc | Stock | 0.67% |
Frequently Asked Questions About Direxion Daily S&P Biotech Bull 3X ETF Holdings
What are the top holdings in LABU?
Direxion Daily S&P Biotech Bull 3X ETF (LABU) holds 169 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is LABU's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review LABU's holdings table to analyze concentration risk.
What is LABU's sector allocation?
The Sector Allocation chart shows how LABU distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does LABU invest in?
LABU's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is LABU ETF?
LABU's diversification can be assessed by reviewing its 169 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.